QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raychaudhuri, P Articles by Nevins, J R Search for Related Content PubMed PubMed Citation Articles by Raychaudhuri, P Articles by Nevins, J R Social Bookmarking                   What's this?

Research Papers

Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes.

Howard Hughes Medical Institute, Department of Microbiology and Immunology, Duke University Medical Center, Durham, North Carolina 27710.

Abstract

Recent experiments have shown that the cellular E2F transcription factor is found in complexes with cellular proteins and that one such complex contains the cyclin-A protein. Isolation of a cellular activity, which we term E2F-BF, can reconstitute the E2F-cyclin-A complex and has permitted a more detailed analysis of the mechanism of E1A dissociation. Through the analysis of a series of E1A mutants, we find that sequences in conserved region 1 (CR1) and conserved region 2 (CR2) are important for dissociation of the E2F complex, whereas amino-terminal sequences are not required. In contrast to the requirements for dissociation, only the CR1 sequences are required to block formation of the complex if E1A is added when the components are combined. We have also identified an activity, termed E2F-I, that inhibits E2F binding to DNA, again apparently through the formation of a complex with E2F. This inhibitory activity is also blocked by E1A, dependent on the same elements of the E1A protein that disrupt the interaction with E2F-BF. Because the E1A sequences that are important for releasing E2F from these interactions are also sequences necessary for oncogenesis, we suggest that this activity may be a critical component of the transforming activity of E1A.

CiteULike

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				L. A. Seifried, S. Talluri, M. Cecchini, L. M. Julian, J. S. Mymryk, and F. A. Dick pRB-E2F1 Complexes Are Resistant to Adenovirus E1A-Mediated Disruption J. Virol., May 1, 2008; 82(9): 4511 - 4520. [Abstract] [Full Text] [PDF]

				X. Liu and R. Marmorstein Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor Genes & Dev., November 1, 2007; 21(21): 2711 - 2716. [Abstract] [Full Text] [PDF]

				J. DeGregori Surprising Dependency for Retinoblastoma Protein in Ras-Mediated Tumorigenesis Mol. Cell. Biol., February 15, 2006; 26(4): 1165 - 1169. [Full Text] [PDF]

				Q. Deng, Y. Li, D. Tedesco, R. Liao, G. Fuhrmann, and P. Sun The Ability of E1A to Rescue ras-Induced Premature Senescence and Confer Transformation Relies on Inactivation of Both p300/CBP and Rb Family Proteins Cancer Res., September 15, 2005; 65(18): 8298 - 8307. [Abstract] [Full Text] [PDF]

				A.-M. Helt and D. A. Galloway Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins Carcinogenesis, February 1, 2003; 24(2): 159 - 169. [Abstract] [Full Text] [PDF]

				J. Deng, F. Kloosterbooer, W. Xia, and M.-C. Hung The NH2-Terminal and Conserved Region 2 Domains of Adenovirus E1A Mediate Two Distinct Mechanisms of Tumor Suppression Cancer Res., January 1, 2002; 62(2): 346 - 350. [Abstract] [Full Text] [PDF]

				M. Tohkin, M. Fukuhara, G. Elizondo, S. Tomita, and F. J. Gonzalez Aryl Hydrocarbon Receptor Is Required for p300-Mediated Induction of DNA Synthesis by Adenovirus E1A Mol. Pharmacol., October 1, 2000; 58(4): 845 - 851. [Abstract] [Full Text]

				A. Mal, D. Chattopadhyay, M. K. Ghosh, R. Y.C. Poon, T. Hunter, and M. L. Harter p21 and Retinoblastoma Protein Control the Absence of DNA Replication in Terminally Differentiated Muscle Cells J. Cell Biol., April 17, 2000; 149(2): 281 - 292. [Abstract] [Full Text] [PDF]

				C. Albanese, M. D'Amico, A. T. Reutens, M. Fu, G. Watanabe, R. J. Lee, R. N. Kitsis, B. Henglein, M. Avantaggiati, K. Somasundaram, et al. Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis J. Biol. Chem., November 26, 1999; 274(48): 34186 - 34195. [Abstract] [Full Text] [PDF]

				G. Evan and T. Littlewood A Matter of Life and Cell Death Science, August 28, 1998; 281(5381): 1317 - 1322. [Abstract] [Full Text]

				M. R. Bennett, K. Macdonald, S.-W. Chan, J. J. Boyle, and P. L. Weissberg Cooperative Interactions Between RB and p53 Regulate Cell Proliferation, Cell Senescence, and Apoptosis in Human Vascular Smooth Muscle Cells From Atherosclerotic Plaques Circ. Res., April 6, 1998; 82(6): 704 - 712. [Abstract] [Full Text] [PDF]

				B. L. Kelly, K. G. Wolfe, and J. M. Roberts Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein PNAS, March 3, 1998; 95(5): 2535 - 2540. [Abstract] [Full Text] [PDF]

				D G Johnson, K Ohtani, and J R Nevins Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes & Dev., July 1, 1994; 8(13): 1514 - 1525. [Abstract] [PDF]

				T. Guadagno, M Ohtsubo, J. Roberts, and R. Assoian A link between cyclin A expression and adhesion-dependent cell cycle progression Science, December 3, 1993; 262(5139): 1572 - 1575. [Abstract] [PDF]

				Nevins JR E2F: a link between the Rb tumor suppressor protein and viral oncoproteins Science, October 16, 1992; 258(5081): 424 - 429. [Abstract] [PDF]

				E Lees, B Faha, V Dulic, S I Reed, and E Harlow Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes & Dev., October 1, 1992; 6(10): 1874 - 1885. [Abstract] [PDF]

				M Pagano, G Draetta, and P Jansen-Durr Association of cdk2 kinase with the transcription factor E2F during S phase Science, February 28, 1992; 255(5048): 1144 - 1147. [Abstract] [PDF]

				S W Hiebert, S P Chellappan, J M Horowitz, and J R Nevins The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes & Dev., February 1, 1992; 6(2): 177 - 185. [Abstract] [PDF]

				R. Weinberg Tumor suppressor genes Science, November 22, 1991; 254(5035): 1138 - 1146. [Abstract] [PDF]

				S. Guo, S. B. Cichy, X. He, Q. Yang, M. Ragland, A. K. Ghosh, P. F. Johnson, and T. G. Unterman Insulin Suppresses Transactivation by CAAT/Enhancer-binding Proteins beta (C/EBPbeta ). SIGNALING TO p300/CREB-BINDING PROTEIN BY PROTEIN KINASE B DISRUPTS INTERACTION WITH THE MAJOR ACTIVATION DOMAIN OF C/EBPbeta J. Biol. Chem., March 9, 2001; 276(11): 8516 - 8523. [Abstract] [Full Text] [PDF]

				D. Tang, H. Okada, J. Ruland, L. Liu, V. Stambolic, T. W. Mak, and A. J. Ingram Akt Is Activated in Response to an Apoptotic Signal J. Biol. Chem., August 3, 2001; 276(32): 30461 - 30466. [Abstract] [Full Text] [PDF]